The timing and intensity of this war were harsh triggers, and many need treatment, but even those without a diagnosis would ...

Texas allocates $50 million to UT-led IMPACT partnership for ibogaine clinical trials treating PTSD, addiction, and more.

A new window may be opening on the treatment of chronic PTSD (post-traumatic stress disorder). Results of a newly published clinical trial suggest that repeated infusions of the drug ketamine over a 2 ...

Post-traumatic stress disorder (PTSD) is among the most challenging mental health conditions to treat effectively. While ...

Potentia Lab, a behavior changing technology platform, today announced that it has won a contract with the Department of Veterans Affairs' Center for Innovation to develop its e-learning platform for ...

MIAMI, FLORIDA / ACCESS Newswire / September 16, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel oral therapeutics ...